MDMA alters emotional processing and facilitates positive social interaction

Psychopharmacology

Volumn 231, Issue 21, 2014, Pages 4219-4229

  Wardle, Margaret C ^a   De Wit, Harriet ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Ecstasy; Emotion perception; MDMA; Psychophysiology; Social cognition; Social interaction

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PSYCHEDELIC AGENT;

ADOLESCENT; ADULT; AFFECT; BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EMOTION; EMPATHY; FEMALE; HEART RATE; HUMAN; HUMAN RELATION; MALE; SOCIAL BEHAVIOR; YOUNG ADULT;

ADOLESCENT; ADULT; AFFECT; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EMOTIONS; EMPATHY; FEMALE; HALLUCINOGENS; HEART RATE; HUMANS; INTERPERSONAL RELATIONS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 84925482650     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3570-x     Document Type: Article

References (47)

1. Bates DM, Meachler M, Bolker B (2011) lme4: linear mixed-effects model using S4 classes
2. Bedi G, Hyman D, de Wit H (2010) Is ecstasy an empathogen? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry 68:1134-1140
3. Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207:73-83
4. Benton CP, Etchells PJ, Porter G, Clark AP, Penton-Voak IS, Nikolov SG (2007) Turning the other cheek: the viewpoint dependence of facial expression after-effects. Proc Royal Soc B: Biol Sci 274:2131-2137
5. Bouso JC, Doblin R, Farré M, Alcázar MÁ, Gómez-Jarabo G (2008) MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. J Psychoactive Drugs 40:225-236
6. Dimberg U, Karlsson B (1997) Facial reactions to different emotionally relevant stimuli. Scand J Psychol 38:297-303
7. Dimberg U, Thunberg M, Elmehed K (2000) Unconscious facial reactions to emotional facial expressions. Psychol Sci 11:86-89
8. First MB, Spitzer RL, Gibbon M, Williams JB (1996) Strutured clinical interview for DSM-IV axis I disorders. Biometrics Research Department, New York
9. Frye CG, Wardle MC, Norman GJ, de Wit H (2014) MDMA decreases the effects of simulated social rejection. Pharmacol, Biochem Behav 117:1-6
10. Gabbay FH (2003) Variations in affect following amphetamine and placebo: markers of stimulant drug preference. Exp Clin Psychopharmacol 11:91-101
11. Gospic K, Gunnarsson T, Fransson P, Ingvar M, Lindefors N, Petrovic P (2008) Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology 197:295-307
12. Griffiths RR, Bigelow GE, Ator NA (2003) Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend 70:S41-S54
13. Harmer CJ (2008) Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 55:1023-1028
14. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256-1263
15. Harris D, Baggott M, Mendelson J, Mendelson J, Jones R (2002) Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 162:396-405
16. Hysek C, Domes G, Liechti M (2012) MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions. Psychopharmacology (Berl): 1-10
17. Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Preller KH, Quednow BB, Liechti ME (2013) MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci. doi: 10.1093/scan/nst161
18. Hysek CM, Simmler LD, Schillinger N, Meyer N, Schmid Y, Donzelli M, Grouzmann E, Liechti ME (2014) Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. Int J Neuropsychopharmacol 17:371-381
19. Janowsky DS (2003) Depression and dysphoria effects on the interpersonal perception of negative and positive moods and caring relationships: effects of antidepressants, amphetamine, and methylphenidate. Curr Psychiatry Rep 5:451-459
20. Janowsky DS, Clopton P, Leichner PP, Abrams AA, Judd LL, Pechnick R (1979) Interpersonal effects of marijuana: a model for the study of interpersonal psychopharmacology. Arch Gen Psychiatry 36:781-785
21. Johansen P, Krebs T (2009) How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale. J Psychopharmacol (Oxf) 23:389-391
22. Kirkpatrick MG, de Wit H (2013) In the company of others: social factors alter acute alcohol effects. Psychopharmacology 230:215-226
23. Kirkpatrick MG, Lee R, Wardle MC, Jacob S, de Wit H (2014) Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacol. doi: 10.1038/npp.2014.12
24. LaBar KS, Crupain MJ, Voyvodic JT, McCarthy G (2003) Dynamic perception of facial affect and identity in the human brain. Cereb Cortex 13:1023-1033
25. Larsen JT, Norris CJ, Cacioppo JT (2003) Effects of positive and negative affect on electromyographic activity over zygomaticus major and corrugator supercilii. Psychophysiology 40:776-785
26. Lieb R, Schuetz CG, Pfister H, von Sydow K, Wittchen H-U (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68:195-207
27. Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154:161-168
28. Liechti ME, Vollenweider FX (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol: Clin Exp 16:589-598
29. Marrone GF, Pardo JS, Krauss RM, Hart CL (2010) Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech. Psychopharmacology 208:169-177
30. Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011) The safety and efficacy of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol (Oxf) 25:439-52
31. Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol (Oxf) 27:28-39
32. Moody EJ, McIntosh DN, Mann LJ, Weisser KR (2007) More than mere mimicry? The influence of emotion on rapid facial reactions to faces. Emotion 7:447-457
33. Oehen P, Traber R, Widmer V, Schnyder U (2013) A randomized, controlled pilot study of MDMA (±3,4-methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol (Oxf) 27:40-52
34. Pennebaker JW, Booth RJ, Francis ME (2007) Linguistic Inquiry and Word Count: LIWC 2007. LIWC, Austin, TX
35. Platt B, Kamboj S, Morgan CJA, Curran HV (2010) Processing dynamic facial affect in frequent cannabis-users: evidence of deficits in the speed of identifying emotional expressions. Drug Alcohol Depend 112:27-32
36. Development Core Team R (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
37. Soar K, Turner JJD, Parrott AC (2006) Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. J Psychopharmacol (Oxf) 20:417-424
38. Sumnall HR, Cole JC, Jerome L (2006) The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J Psychopharmacol (Oxf) 20:670-682
39. Tancer M, Johanson C-E (2007) The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 189:565-573
40. Ter Bogt TFM, Engels RCME (2005) "Partying" hard: party style, motives for and effects of MDMA use at rave parties. Subst Use Misuse 40:1479-1502
41. Tremblay LK, Naranjo CA, Graham SJ et al (2005) Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62:1228-1236
42. Vollenweider FX, Gamma A, Liechti M, Huber T (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241-251
43. Walter NT, Mutic S, Markett S, Montag C, Klein AM, Reuter M (2011) The influence of alcohol intake and alcohol expectations on the recognition of emotions. Alcohol Alcohol 46:680-685
44. Wardle M, Cederbaum K, de Wit H (2011) Quantifying talk: developing reliable measures of verbal productivity. Beh Res Methods 43:168-178
45. Wardle M, de Wit H (2012) Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology 220:143-153
46. Wardle M, Garner M, Munafò M, de Wit H (2012) Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Psychopharmacology (Berl): 1-12
47. White TL, Justice AJH, de Wit H (2002) Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol, Biochem Behav 73:729-741